Medical News

Serum AKR1B10: A Promising Marker for Detection of Hepatocellular Carcinoma

The diagnostic accuracy of aldo-keto reductase family 1 member B10 (AKR1B10) was superior to alpha-fetoprotein (AFP) for detection of hepatocellular...

08 Feb, 2019

 
Email this page
Risk of Hepatocellular Carcinoma in Patients with High Serum HBcrAg Levels Following Nucleos(t)ide Analogue Therapy

Chronic hepatitis B patients with persistently high-on treatment serum hepatitis B core-related antigen (HBcrAg) levels following nucleos(t)ide...

29 Jan, 2019

 
Email this page
Multiparametric Magnetic Resonance Imaging Useful in Predicting Disease Progression in Prostate Cancer Patients

Multiparametric magnetic resonance imaging (mpMRI) could be a useful tool to monitor the disease progression in the patients of prostate cancer (PCa...

24 Dec, 2018

 
Email this page
BCG Immunotherapy and Toxicity in Non-Muscle Invasive Bladder Cancer Might Not be Predicted by Mantoux Tuberculin Skin Test

Mantoux tuberculin skin test (TST) cannot be used as a significant predictor of bladder cancer recurrence, progression or cancer specific survival...

17 Dec, 2018

 
Email this page

Our Publications

Pomalong (Pomalidomide) Monograph

Pomalidomide-dexamethasone is a standard of care in patients with relapsed/refractory multiple myeloma following exhaustion of treatment options.

Slide Library

Management of Advanced Prostate Cancer: Current Concepts

Prostate cancer has become a major public health burden worldwide and its incidence rates are increasing in India.  Hormonal therapy or androgen...

 
Email this page
Clinical Appraisal of Abiraterone acetate in Management of CRPC

Prostate cancer has become a major public health burden worldwide. Castration or hormonal therapy is the mainstay of treatment for the management of...

 
Email this page
HBV Reactivation in Patients Undergoing Chemotherapy

The risk of hepatitis B virus (HB) reactivation is high in patients receiving chemotherapy for solid or hematological malignancies which may lead to...

 
Email this page
Lung Cancer

This slide set provides information on types of lung cancer,epidemiology, pathophysiology, risk factors/causes, clinical features, diagnosis,...

 
Email this page

Key Trials

Early Use of Vacuum Therapy Has an Excellent Therapeutic Effect in Men undergoing Radical Prostatectomy

Early use of vacuum therapy significantly improved the erectile dysfunction and penile shrinkage in men post radical prostatectomy (RP) and enhanced...

Survival Outcomes with Extended and Limited Lymph Node Dissection in Bladder Cancer Patients undergoing Radical Cystectomy

A recent prospective study concluded that the extended lymph node dissection (LND) in bladder cancer patients undergoing radical cystectomy did not...

Enzalutamide and Abiraterone Improved Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer

Enzalutamide was the most effective in prolonging the progression-free survival,  followed by abiraterone and tasquinimod in patients with...

BCG Therapy Significantly Reduced Recurrence and Progression in High Risk Non-Muscle-Invasive Bladder Cancer

Bacillus Calmette Guerin (BCG) therapy reduced the rate of recurrence in patients at high risk non-muscle invasive bladder cancer (NMIBC),...

Patient Education

All You Wanted to Know about Prostate Cancer

Prostate is one of the most common cancers in men. This material describes risk factors, symptoms, diagnosis and treatment of prostate cancer. Also...

Living with Leukemia/Lymphoma

Tips for patient with leukaemia and lymphoma are explained along with pictures for better understanding. 

All You Wanted to Know about Ovarian Cancer

Risk factors, signs & symptoms, factors known to reduce ovarian cancer, diagnosis, treatment options and how to reduce risk of ovarian cancer...

Myths and Facts about Cancer

Throughout the years there have been many cancer myths floating around. This article will help clear the myths related to cancer.

Infographics

Explore >>

Currently there is no content under this category.

Poll

Your choice of drug in the first-line treatment of patients with metastatic colorectal cancer treatment (CRC)
Capecitabine
43% (3 votes)
Tegafur uracil
0% (0 votes)
5-FU
57% (4 votes)
Total votes: 7